FUNDACJA
Fundacja na Rzecz Programu Wczesnego Rozpoznawania Chorób Nowotworowych u Kobiet Godula - HOPE
Fundacja na Rzecz Programu Wczesnego Rozpoznawania Chorób Nowotworowych u Kobiet Godula - HOPE
FUNDACJA
Fundacja na Rzecz Programu Wczesnego Rozpoznawania Chorób Nowotworowych u Kobiet Godula - HOPE
Fundacja na Rzecz Programu Wczesnego Rozpoznawania Chorób Nowotworowych u Kobiet Godula - HOPE (KRS 0000008844, NIP 6412101392) is a Polish company, headquartered in Ruda Śląska, Śląskie voivodeship. FUNDACJA NA RZECZ PROGRAMU WCZESNEGO ROZPOZNAWANIA CHORÓB NOWOTWOROWYCH U KOBIET GODULA - HOPE operates in: Specialist medical practice activities (PKD 86.22.Z). Industry: Healthcare. The company has been listed in the National Court Register since May 30, 2001.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
86.22.ZSpecialist medical practice activities
Other activities
Credibility rating
44.9 / 100
Average credibility
Insolvency risk
Very low
Elevated threat
Closure risk
16
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/25 yrs
Board changes
2
2/25 yrs
PKD changes
3
3/25 yrs
Name changes
0
0/25 yrs
Data from 25 years of registry activity.
Payment reliability score from 2021–2024
Current: D (45/100)
Trend: deteriorating (-7.5 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Standard limit from 2021–2024
Current: 0 PLN
Safe: 0 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Founded
May 30, 2001
25 years in operation
Legal form
FUNDACJA
Registry: RejP
Headquarters
RUDA ŚLĄSKA
ŚLĄSKIE
Primary PKD
86.22.Z
Specialist medical practice activities
Share capital
N/A
Shareholders
N/A
Board
1 person
Filed years
4 years
2021–2024 · profitable: 2/4
Registry entries
41
latest: January 29, 2026
Risk signals
Revenue
N/A
2024
Net profit
-445.1 K PLN
2024
Assets
4.3 M PLN
2024
Equity
3.3 M PLN
2024
Valuation
2.7 M PLN
Low confidence
Low confidence
Rate business credibility - Fundacja na Rzecz Programu Wczesnego Rozpoznawania Chorób Nowotworowych u Kobiet Godula - HOPE.
No ratings

News
Warsaw-based Longevity Center sp. z o.o. (KRS 0000796083, ul. Belwederska 9) has launched Longevity Academy - one of the first in the world and the first in Poland accredited longevity-medicine educational programme for doctors. Accreditation by the Polish Medical Chamber; scientific partner: the Buck Institute for Research on Aging in California. The programme is built on 6+ years of clinical practice and 3,000+ patients.

Explainer
Voxel S.A. (KRS 0000238176), headquartered at ul. Wielicka 265 in Kraków, is a Polish operator of medical-imaging centre networks (MRI, CT, X-ray, ultrasound, mammography) and a radiopharmaceutical producer. The company was founded in 2005, listed on the WSE since 2011. It operates under the Voxel-Diagnostic brand at several dozen locations across Poland. A two-member management board, a five-member supervisory board.
Latest reporting year
2024
Available years
24
Filing entries
0
20 historical registry entries for foundation Fundacja na Rzecz Programu Wczesnego Rozpoznawania Chorób Nowotworowych u Kobiet Godula - HOPE
Commercial proxy change
GL.X NS-REJ.KRS/9824/24/707
First fiscal year recorded
GL.X NS-REJ.KRS/14559/24/24
Change in Section 1 (basic data)
GL.X NS-REJ.KRS/14559/24/24/ADE
Filing document
Commercial proxy change
GL.X NS-REJ.KRS/179/26/977
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
FUNDACJA NA RZECZ PROGRAMU WCZESNEGO ROZPOZNAWANIA CHORÓB NOWOTWOROWYCH U KOBIET GODULA - HOPE's board has 1 member.
Competing companies or those operating in the same market segment as Fundacja na Rzecz Programu Wczesnego Rozpoznawania Chorób Nowotworowych u Kobiet Godula - HOPE (in Ruda Śląska, industry: Healthcare).
KATOWICE· Healthcare
Revenue 2024: 133.5 M PLN
GLIWICE· Healthcare
Revenue 2023: 124.5 M PLN
SOSNOWIEC· Healthcare
Revenue 2024: 104.2 M PLN
KATOWICE· Healthcare
Revenue 2024: 83.1 M PLN
CHORZÓW· Healthcare
Revenue 2024: 62.8 M PLN
KATOWICE· Healthcare
Revenue 2024: 52.5 M PLN